Advertisements

Indivior shares dive after Dr Reddy"s gets FDA approval for generic

Indivior shares dive after Dr Reddy"s gets FDA approval for generic.....»»

Category: global-financeSource: reutersJun 15th, 2018

Dr. Reddy"s shares spike after favourable generic drug ruling

Dr. Reddy"s shares spike after favourable generic drug ruling.....»»

Category: global-financeSource: reutersNov 21st, 2018

U.S. top court rejects bid to block Indivior opioid drug copycat

U.S. top court rejects bid to block Indivior opioid drug copycat.....»»

Category: global-financeSource: reuters10 hr. 59 min. ago

Indivior wins fresh hold on Dr. Reddy"s Suboxone copy

Indivior wins fresh hold on Dr. Reddy"s Suboxone copy.....»»

Category: global-financeSource: reutersDec 12th, 2018

Indivior says wins fresh hold on Suboxone copy

Indivior says wins fresh hold on Suboxone copy.....»»

Category: global-financeSource: reutersDec 12th, 2018

U.S. court allows generic version of Indivior opioid abuse drug

U.S. court allows generic version of Indivior opioid abuse drug.....»»

Category: global-financeSource: reutersNov 20th, 2018

Dr Reddy#39;s Labs announces generic version of Straterra in US market

Dr Reddy#39;s Labs announces generic version of Straterra in US market.....»»

Category: topSource: moneycontrolOct 31st, 2018

Teva to hold Indivior generic drug launch pending US ruling

Teva to hold Indivior generic drug launch pending US ruling.....»»

Category: topSource: moneycontrolSep 12th, 2018

Indivior says U.S. court rules against generic rival"s appeal

Indivior says U.S. court rules against generic rival"s appeal.....»»

Category: global-financeSource: reutersJul 31st, 2018

U.S. court expedites Indivior rival Dr. Reddy"s appeal to re-launch generic drug

U.S. court expedites Indivior rival Dr. Reddy"s appeal to re-launch generic drug.....»»

Category: global-financeSource: reutersJul 30th, 2018

US court restrains DRL"s sale of Suboxone anti-opioid copy - The Hindu

US court restrains DRL"s sale of Suboxone anti-opioid copy - The Hindu.....»»

Category: topSource: googlenewsJul 14th, 2018

US court prevents Dr Reddy"s from launching opioid treatment drug Suboxone - The Hindu

US court prevents Dr Reddy"s from launching opioid treatment drug Suboxone - The Hindu.....»»

Category: topSource: googlenewsJul 14th, 2018

Indivior wins preliminary injunction against generic rival

Indivior wins preliminary injunction against generic rival.....»»

Category: global-financeSource: reutersJul 14th, 2018

Dr.Reddy’s to sell generic version of opioid addiction treatment Suboxone in U.S.

Dr.Reddy’s to sell generic version of opioid addiction treatment Suboxone in U.S......»»

Category: topSource: the-hinduJun 15th, 2018

Biocon share price surges 15% on FDA nod for generic cancer drug

Biocon share price surges 15% on FDA nod for generic cancer drug.....»»

Category: marketsSource: thehindubusinesslineDec 4th, 2017

Biocon rallies over 14% on FDA approval for biosimilar version of Herceptin

Biocon rallies over 14% on FDA approval for biosimilar version of Herceptin.....»»

Category: marketsSource: thehindubusinesslineDec 4th, 2017

Biocon hits record high on EMA approval for cancer drugs

Biocon hits record high on EMA approval for cancer drugs.....»»

Category: marketsSource: thehindubusinesslineDec 1st, 2017

Glenmark gets USFDA nod for contraceptive drug; shares up 0.4%

Glenmark gets USFDA nod for contraceptive drug; shares up 0.4%.....»»

Category: marketsSource: thehindubusinesslineNov 22nd, 2017

Lupin surges 3% on USFDA approval for hypertension drug

Lupin surges 3% on USFDA approval for hypertension drug.....»»

Category: marketsSource: thehindubusinesslineOct 10th, 2017

Mylan surges, Teva slumps after FDA approves Copaxone copy

Mylan surges, Teva slumps after FDA approves Copaxone copy.....»»

Category: global-financeSource: reutersOct 5th, 2017

Mylan surges, Teva slumps after FDA approves Copaxone copy

Mylan surges, Teva slumps after FDA approves Copaxone copy.....»»

Category: marketsSource: sifyOct 5th, 2017